Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Mesa Laboratories's share price for the quarter that ended in Mar. 2026 was $88.42. Mesa Laboratories's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 5.5 Mil. Therefore, Mesa Laboratories's market cap for the quarter that ended in Mar. 2026 was $488.5 Mil.
Mesa Laboratories's quarterly market cap
increased
from Sep. 2025 ($369.3 Mil) to Dec. 2025 ($433.7 Mil) and
increased
from Dec. 2025 ($433.7 Mil) to Mar. 2026 ($488.5 Mil).
Mesa Laboratories's annual market cap
increased
from Mar. 2024 ($591.9 Mil) to Mar. 2025 ($647.3 Mil) but then
declined
from Mar. 2025 ($647.3 Mil) to Mar. 2026 ($488.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Mesa Laboratories's Enterprise Value for Today is $670.5 Mil.
Mesa Laboratories (NAS:MLAB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Mesa Laboratories Market Cap Related Terms
Mesa Laboratories Market Cap Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories Market Cap vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's Market Cap distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Mesa Laboratories's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories (MLAB) has a Market Cap of $542.4 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Mesa Laboratories and its competitors. According to the industry distribution chart, Mesa Laboratories ranks #899 out of 2513 companies in the Hardware industry, placing it in the top 35.8%.
Is Mesa Laboratories' Market Cap too high?
Mesa Laboratories' current Market Cap is $542.4 Mil. The Hardware industry median Market Cap is 210.64. Mesa Laboratories' value of $542.4 Mil is 157.5% above this industry median. Based on the distribution chart, Mesa Laboratories ranks #899 out of 2513 companies in the Hardware industry, which is above the industry midpoint. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Market Cap compare to AERG and MVIS?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #899 out of 2513 companies for Market Cap. This puts Mesa Laboratories in the upper half of its industry. The industry median Market Cap is 210.64. Mesa Laboratories' value of $542.4 Mil is 157.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Hardware company?
The median Market Cap among Hardware companies is 210.64, based on 2,513 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current Market Cap of $542.4 Mil is 157.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median Market Cap is 210.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current Market Cap is $542.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.05, compared to a current price of $98.18 — trading 15.4% below its estimated fair value. The current Market Cap is $542.4 Mil and 157.5% above the Hardware industry median of 210.64. Mesa Laboratories' overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Market Cap is $542.4 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued.
The current stock price of $98.18 is trading 15.4% below its estimated GF Value™ of $116.05.
GuruFocus considers Mesa Laboratories to be Modestly Undervalued.
Key valuation signals for MLAB:
Market Cap: $542.4 Mil
GF Value™: $116.05 vs. price of $98.18 (15.4% below fair value)
Industry Position: 157.5% above the Hardware median (#899 of 2513)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score
Get the complete analysis for MLAB
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
